ENvue Medical annual revenue
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
ENvue Medical Revenue Growth & History (FEED)
ENvue Medical reported $2.6M in revenue for fiscal 2025, a decrease of 0.20% from the previous fiscal year.
View full ENvue Medical company overviewENvue Medical annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.6M | −$5,000 | −0.20% |
| 2024 | 2024-12-31 | $2.6M | $275,000 | +12.05% |
| 2023 | 2023-12-31 | $2.3M | $1.5M | +203.59% |
| 2022 | 2022-12-31 | $752,000 | −$943,000 | −55.63% |
| 2021 | 2021-12-31 | $1.7M | $1.1M | +172.07% |
| 2020 | 2020-12-31 | $623,000 | $93,000 | +17.55% |
| 2019 | 2019-12-31 | $530,000 | $212,000 | +66.67% |
| 2018 | 2018-12-31 | $318,000 | $79,000 | +33.05% |
| 2017 | 2017-12-31 | $239,000 | $10,000 | +4.37% |
| 2016 | 2016-12-31 | $229,000 | $82,000 | +55.78% |
| 2015 | 2015-12-31 | $147,000 | −$56,000 | −27.59% |
| 2014 | 2014-12-31 | $203,000 | — | — |
ENvue Medical quarterly revenue
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q4.20
Q1.21
Q2.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $239,000 | −$255,000 | −51.62% |
| Q1 2026 | 2026-03-31 | $653,000 | −$372,000 | −36.29% |
| Q4 2025 | 2025-12-31 | $312,000 | −$132,000 | −29.73% |
| Q3 2025 | 2025-09-30 | $722,000 | $346,000 | +92.02% |
| Q2 2025 | 2025-06-30 | $494,000 | −$323,000 | −39.53% |
| Q1 2025 | 2025-03-31 | $1.0M | $104,000 | +11.29% |
| Q4 2024 | 2024-12-31 | $444,000 | −$733,000 | −62.28% |
| Q3 2024 | 2024-09-30 | $376,000 | −$82,000 | −17.90% |
| Q2 2024 | 2024-06-30 | $817,000 | $523,000 | +177.89% |
| Q1 2024 | 2024-03-31 | $921,000 | $567,000 | +160.17% |
| Q4 2023 | 2023-12-31 | $1.2M | $1.3M | +1253.92% |
| Q3 2023 | 2023-09-30 | $458,000 | $361,000 | +372.16% |
| Q2 2023 | 2023-06-30 | $294,000 | −$191,000 | −39.38% |
| Q1 2023 | 2023-03-31 | $354,000 | $82,000 | +30.15% |
| Q4 2022 | 2022-12-31 | −$102,000 | −$877,000 | −113.16% |
| Q3 2022 | 2022-09-30 | $97,000 | −$402,000 | −80.56% |
| Q2 2022 | 2022-06-30 | $485,000 | $167,000 | +52.52% |
| Q1 2022 | 2022-03-31 | $272,000 | $169,000 | +164.08% |
| Q4 2021 | 2021-12-31 | $775,000 | $685,000 | +761.11% |
| Q2 2021 | 2021-09-30 | $499,000 | $349,000 | +232.67% |
| Q1 2021 | 2021-06-30 | $318,000 | $49,000 | +18.22% |
| Q4 2020 | 2021-03-31 | $103,000 | −$11,000 | −9.65% |
| Q4 2020 | 2020-12-31 | $90,000 | $3,000 | +3.45% |
| Q3 2020 | 2020-09-30 | $150,000 | $49,000 | +48.51% |
| Q2 2020 | 2020-06-30 | $269,000 | $6,000 | +2.28% |
| Q1 2020 | 2020-03-31 | $114,000 | $35,000 | +44.30% |
| Q4 2019 | 2019-12-31 | $87,000 | $32,000 | +58.18% |
| Q3 2019 | 2019-09-30 | $101,000 | $47,000 | +87.04% |
| Q2 2019 | 2019-06-30 | $263,000 | $131,000 | +99.24% |
| Q1 2019 | 2019-03-31 | $79,000 | $2,000 | +2.60% |
| Q4 2018 | 2018-12-31 | $55,000 | −$15,000 | −21.43% |
| Q3 2018 | 2018-09-30 | $54,000 | −$11,000 | −16.92% |
| Q2 2018 | 2018-06-30 | $132,000 | $80,000 | +153.85% |
| Q1 2018 | 2018-03-31 | $77,000 | $25,000 | +48.08% |
| Q4 2017 | 2017-12-31 | $70,000 | $21,000 | +42.86% |
| Q3 2017 | 2017-09-30 | $65,000 | $4,000 | +6.56% |
| Q2 2017 | 2017-06-30 | $52,000 | −$10,000 | −16.13% |
| Q1 2017 | 2017-03-31 | $52,000 | −$5,000 | −8.77% |
| Q4 2016 | 2016-12-31 | $49,000 | $10,000 | +25.64% |
| Q3 2016 | 2016-09-30 | $61,000 | $21,000 | +52.50% |
| Q2 2016 | 2016-06-30 | $62,000 | $23,000 | +58.97% |
| Q1 2016 | 2016-03-31 | $57,000 | $28,000 | +96.55% |
| Q4 2015 | 2015-12-31 | $39,000 | −$137,000 | −77.84% |
| Q3 2015 | 2015-09-30 | $40,000 | $15,000 | +60.00% |
| Q2 2015 | 2015-06-30 | $39,000 | −$25,000 | −39.06% |
| Q1 2015 | 2015-03-31 | $29,000 | $91,000 | +146.77% |
| Q4 2014 | 2014-12-31 | $176,000 | — | — |
| Q3 2014 | 2014-09-30 | $25,000 | — | — |
| Q2 2014 | 2014-06-30 | $64,000 | — | — |
| Q1 2014 | 2014-03-31 | −$62,000 | — | — |
ENvue Medical revenue growth trends
Over the last five reported fiscal years, revenue grew from $623,000 to $2.6M, a compound annual growth rate of 32.59%. ENvue Medical's latest reported quarter, Q2 2026, generated $239,000 in revenue, a decrease of 51.62% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review ENvue Medical source filings ↗